SCHEMBL14893262

SCHEMBL14893262

[CH2]C(=O)NC(C(=O)O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.51
LMNA P02545 2/20 0.50
MAPK1 P28482 1/20 0.50
NAALAD2 Q9Y3Q0 1/20 0.50
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
SRC P12931 2/20 0.46
CYP2D6 P10635 1/20 0.46
LTA4H P09960 1/20 0.44
ANPEP P15144 1/20 0.44
ATM Q13315 1/20 0.44
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28851390 0.83 FPR2 (0.54) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL8750970 0.83 FPR2 (0.54) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL3376625 0.79 SRC (0.52) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL4250144 0.79 SRC (0.52) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL29865850 0.79 LMNA (0.53) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL13707813 0.79 FPR2 (0.51) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL627377 0.79 SRC (0.52) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL7471144 0.79 LMNA (0.53) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL13707806 0.79 FPR2 (0.51) FPR2LMNAMAPK1NAALAD2CA1
SCHEMBL10576600 0.79 LMNA (0.53) FPR2LMNAMAPK1NAALAD2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2770990-A1 BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE Lumena Pharmaceuticals, Inc. (US) 2014-09-03 EP disclosed
EP-2771003-A1 BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES Lumena Pharmaceuticals, Inc. (US) 2014-09-03 EP disclosed
WO-2013063512-A1 BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES LUMENA PHARMACEUTICALS, INC (US) 2013-05-02 WO disclosed
WO-2013063526-A1 BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE Lumena Pharmaceuticals, Inc. (US) 2013-05-02 WO disclosed